GU ASCO annual meeting featured a prostate cancer session and a presentation by Dr. Miguel Muniz discussing outcomes for 177 Lu-PSMA-617 with and without concurrent use of androgen receptor pathway ...
Quality of life, treatment impact and duration, and the importance of individualized therapy are at the center of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback